
Sabin Vaccine Institute begins trial of vaccine candidate for Marburg virus disease
The Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being given to subjects in Melbourne, Florida. The trial aims to enrol 200 subjects aged 18 to 70 years at sites in Alabama, Illinois and …